Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0616619980040010049
Journal of Soonchunhyang Medical College
1998 Volume.4 No. 1 p.49 ~ p.55
The Changes of Lipid Profiles according to Administration Method of Progestogen during Hormone Replacement Therapy in Postmenopausal Women







Abstract
Objective : The purpose of our study is to evaluate the effect of different administration method of progestogen on lipid profiles including total cholesterol, LDL(low density lipoprotein)-cholesterol, HDL(high density lipoprotein)-cholesterol, triglycerides during hormone replacement therapy in postmenopausal women.
Methods and Materials : Seventy-one postmenopausal women who were assigned to following groups (Group I : conjugated equine estrogen(CEE), 0.625 mg/day plus continuous medroxyprogesterone acetate (MPA), 2.5mg/day, Group II : CEE, 0.625 mg/day plus cyclic MPA, 5mg/day for 12days/month. And we measured serum total cholesterol, high density lipoprotein (HDL)-cholesterol, low density lipoprotein (LDL)-cholesterol, and triglycerides before hormone replacement therapy(HRT) and 12 months later after hormone replacement therapy.
Results:
1. Total cholesterol decreased in group I,III.
2. HDL-cholesterol increased in group I,II,III.
3. LDL-cholesterol decrease in group I,II.
4. Triglycerides increased in group I,II,III.
There was significance in serum total cholesterol and LDL-cholestrerol among three groups.
Conclusions : Estrogen alone or in combination with progestogen both in cyclic and continuous use improves lipid profiles, so medroxyprogesterone acetate(MPA) does not seem to blunt estrogenic effect on lipid profiles.
KEYWORD
FullTexts / Linksout information
Listed journal information